SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021
Article
[키워드] antibody
antibody level
baseline characteristics
body mass
cardiovascular disease
Chronic kidney disease
chronic obstructive
Comorbidity
Concentration
conducted
congestive heart failure
coronavirus
COVID-19
COVID-19 vaccination
COVID-19 vaccine
cut-off
diabete
dose
Factor
female
first dose
geometric mean
GFR
glomerular filtration rate
GMC
GMCs
IgG
IgG antibodies
IgG antibody
Immunosuppression
Infection
Inflammatory bowel disease
levels of antibody
male
mRNA
Patient
peaked
pulmonary disease
remained
repeated
reported
resource
retrospective cohort study
SARS-CoV-2
SARS-CoV-2 spike
serological
serology
solid malignancy
the antibody
the SARS-CoV-2
titre
vaccination
were used
[DOI] 10.2807/1560-7917.ES.2022.27.40.2100703 PMC 바로가기
[DOI] 10.2807/1560-7917.ES.2022.27.40.2100703 PMC 바로가기